EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC

Oraianthi Fiste iD, Ioannis Gkiozos iD, Andriani Charpidou iD, Nikolaos K Syrigos iD

Cancers · 19.02.2024 · 16 (4) · 831

DOI: 10.3390/cancers16040831 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 19.02.2024. Verfasst von Oraianthi Fiste und 3 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Unit, Third Department of Internal Medicine and Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Gr…. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality among women and men, in developed countries, despite the public health interventions including tobacco-free campaigns, screening and early detection methods, recent therapeutic advances, and ongoing intense research on novel antineoplastic modalities. Targeting oncogenic driver mutations and immune checkpoint inhibition has indeed revolutionized NSCLC treatment, yet there still remains the unmet need for robust and standardized predictive biomarkers to accurately inform clinical decisions. Artificial intelligence (AI) represents the computer-based science concerned with large datasets for complex problem-solving. Its concept has brought a paradigm shift in oncology considering its immense potential for improved diagnosis, treatment guidance, and prognosis. In this review, we present the current state of AI-driven applications on NSCLC management, with a particular focus on radiomics and pathomics, and critically discuss both the existing limitations and future directions in this field. The thoracic oncology community should not be discouraged by the likely long road of AI implementation into daily clinical practice, as its transformative impact on personalized treatment approaches is undeniable.

Schlagwörter

Stichwörter der Autor:innen

AIartificial intelligencebig databiomarkerslung cancermachine learningnon-small cell lung cancerpathomicsradiomicstreatment

Autor:innen und Institutionen

  • Oncology Unit, Third Department of Internal Medicine and Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

ORCID-Profile: Oraianthi Fiste, Ioannis Gkiozos, Andriani Charpidou, Nikolaos K Syrigos

Zitieren

APA

Fiste, O., Gkiozos, I., Charpidou, A., & Syrigos, N. K. (2024). Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC. Cancers, 16(4), 831. https://doi.org/10.3390/cancers16040831

Vancouver

Fiste O, Gkiozos I, Charpidou A, Syrigos NK. Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC. Cancers. 2024;16(4):831. doi:10.3390/cancers16040831

BibTeX
@article{Fiste2024,
  author = {Fiste, Oraianthi and Gkiozos, Ioannis and Charpidou, Andriani and Syrigos, Nikolaos K},
  title = {Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {4},
  pages = {831},
  doi = {10.3390/cancers16040831}
}
Kostenlos starten →